HRSA Delays 340B Ceiling Price Rule To July 2018, Plans More Rules

The Health Resources and Services Administration again delayed, this time until July 2018, a rule that sets civil money penalties and ceiling prices for drugs in the 340B discount program. The agency says it needs more time to study regulatory burdens the rule would impose. “While stakeholders had the opportunity to provide comments on the final rule, the 340B Program is a complex program that is affected by changes in other areas of health care. HHS has determined that this...